diosgenin has been researched along with B16 Melanoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, JX; Chen, YJ; Chou, JY; Fu, XQ; Li, JK; Li, SM; Liu, YX; Niu, XD; Wang, XQ; Wu, JY; Wu, Y; Xu, BW; Yin, CL; Yu, ZL | 1 |
| Huang, W; Li, L; Li, S; Li, Y; Ming, Y; Niu, H; Wang, H; Wei, Z; Xin, G; Xing, Z; Zeng, Z; Zhang, B; Zhang, J; Zhang, X | 1 |
| Du, B; Ji, L; Kou, Y; Liu, L; Liu, Z; Lu, L; Qi, X; Wang, H; Wang, W; Zheng, H; Zou, J | 1 |
| Mahmood, R; Malojirao, VH; Prabhakar, BT; Thirusangu, P; Vigneshwaran, V | 1 |
| Ebina, K; Fukatsu, M; Kimura, H; Koketsu, M; Ninomiya, M; Nishina, A; Sato, D; Ukiya, M | 1 |
| Du, B; Li, B; Liu, X; Tan, Y; Wu, Y; Xiao, J; Zhang, G | 1 |
| Jung, K; Kim, YS; Lee, J; Park, D | 1 |
7 other study(ies) available for diosgenin and B16 Melanoma
| Article | Year |
|---|---|
Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Diosgenin; Human Umbilical Vein Endothelial Cells; Humans; Male; Melanoma, Experimental; Mice, Inbred C57BL; Neovascularization, Pathologic; src-Family Kinases; STAT3 Transcription Factor; Tumor Burden | 2022 |
A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Diosgenin; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice, Inbred BALB C; Nanoparticles; Prodrugs; Skin Neoplasms; Tissue Distribution | 2020 |
Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization.
Topics: Animals; Connexin 43; Diosgenin; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; RAW 264.7 Cells; Up-Regulation | 2017 |
The tumor antagonistic steroidal alkaloid Solanidine prompts the intrinsic suicidal signal mediated DFF-40 nuclear import and nucleosomal disruption.
Topics: A549 Cells; Active Transport, Cell Nucleus; Alkaloids; Animals; Cell Death; Deoxyribonucleases; Diosgenin; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nucleosomes; Poly-ADP-Ribose Binding Proteins; Xenograft Model Antitumor Assays | 2018 |
Dioscin Derived from Solanum melongena L. "Usukawamarunasu" Attenuates α-MSH-Induced Melanogenesis in B16 Murine Melanoma Cells via Downregulation of Phospho-CREB and MITF.
Topics: alpha-MSH; Animals; Cyclic AMP Response Element-Binding Protein; Diosgenin; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Intramolecular Oxidoreductases; Melanins; Melanoma, Experimental; Membrane Glycoproteins; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Oxidoreductases; Phosphorylation; Plant Extracts; Solanum melongena | 2015 |
Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Topics: Animals; Antiviral Agents; Bystander Effect; Cell Communication; Cell Survival; Connexin 26; Connexin 43; Connexins; Diosgenin; Disease Models, Animal; Drug Synergism; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Melanoma, Experimental; Mice; Mutation; Simplexvirus; Thymidine Kinase; Tumor Cells, Cultured | 2017 |
Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromones; Diosgenin; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Morpholines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction | 2007 |